Literature DB >> 20297785

Azide-tetrazole equilibrium of C-6 azidopurine nucleosides and their ligation reactions with alkynes.

Mahesh K Lakshman1, Manish K Singh, Damon Parrish, Raghavan Balachandran, Billy W Day.   

Abstract

Facile syntheses of C-6 azidopurine ribonucleosides and 2'-deoxyribonucleosides have been developed. For silyl- and acetyl-protected as well as unprotected nucleosides, access to the azido derivatives could be readily attained via displacement of BtO(-) from the O(6)-(benzotriazol-1-yl)inosine nucleosides by azide anion. Use of diphenylphosphoryl azide/DBU as a simple route to the acetyl-protected azido nucleosides was also evaluated, but this proved to be inferior. Since these azido nucleosides can exist in an azide.tetrazole equilibrium, the effect of solvent polarity on this equilibrium was investigated. Subsequently, a detailed analysis of Cu-mediated azide-alkyne ("click") ligation was undertaken. Biphasic CH(2)Cl(2)/H(2)O medium proved to be best for the ligation reactions, suppressing the undesired azide reduction that was competing. Interestingly, although the tetrazolyl isomer predominates (ca. 80%) in CD(2)Cl(2) and in CD(2)Cl(2)/D(2)O, the Cu-catalyzed click reactions proceed smoothly with the silyl-protected ribo- and 2'-deoxyribonucleosides, leading to the C-6 triazolyl products in good to excellent yields. Thus, depletion of the azido form from the reaction mixture shifts the azide.tetrazole equilibrium, eventually resulting in complete consumption of azide and tetrazole. In several cases, major and minor azide-alkyne ligation products were observed, and characterization data are provided for both. In order to confirm the regiochemistry leading to the major isomer, one product was crystallized and evaluated by X-ray crystallography. The Cu-catalyzed azide-alkyne ligation is clearly efficient and significantly superior to thermal reactions, which were slow. Biological evaluation showed low cytotoxicities for the agents, suggesting their usefulness as biological probes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20297785      PMCID: PMC2877261          DOI: 10.1021/jo902342z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  34 in total

1.  Synthesis and reactions of 6-methylsulfonyl-9-beta-D-ribofuranosylpurine.

Authors:  R Wetzel; F Eckstein
Journal:  J Org Chem       Date:  1975-03-07       Impact factor: 4.354

2.  Nucleosides and oligonucleotides with diynyl side chains: the huisgen-sharpless cycloaddition "click reaction" performed on DNA and their constituents.

Authors:  Frank Seela; Venkata Ramana Sirivolu
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2007       Impact factor: 1.381

3.  Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis.

Authors:  Amol Gupte; Helena I Boshoff; Daniel J Wilson; João Neres; Nicholas P Labello; Ravindranadh V Somu; Chengguo Xing; Clifton E Barry; Courtney C Aldrich
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

4.  Synthesis and polymerase chain reaction amplification of DNA strands containing an unnatural triazole linkage.

Authors:  Afaf H El-Sagheer; Tom Brown
Journal:  J Am Chem Soc       Date:  2009-03-25       Impact factor: 15.419

Review 5.  Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.

Authors:  Rhalid Akkari; Joachim C Burbiel; Jörg Hockemeyer; Christa E Müller
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

6.  2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.

Authors:  Liesbet Cosyn; Krishnan K Palaniappan; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson; Serge Van Calenbergh
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

7.  Synthesis, biotransformation, and pharmacokinetic studies of 9-(beta-D-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathway.

Authors:  L P Kotra; K K Manouilov; E Cretton-Scott; J P Sommadossi; F D Boudinot; R F Schinazi; C K Chu
Journal:  J Med Chem       Date:  1996-12-20       Impact factor: 7.446

8.  Triazole-linked dumbbell oligodeoxynucleotides with NF-kappaB binding ability as potential decoy molecules.

Authors:  Masanori Nakane; Satoshi Ichikawa; Akira Matsuda
Journal:  J Org Chem       Date:  2008-02-01       Impact factor: 4.354

9.  A novel polymer supported approach to nucleoside modification.

Authors:  Suyeal Bae; Mahesh K Lakshman
Journal:  J Org Chem       Date:  2008-04-23       Impact factor: 4.354

10.  N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists.

Authors:  T D Ashton; Stephen P Baker; Sally A Hutchinson; Peter J Scammells
Journal:  Bioorg Med Chem       Date:  2007-11-06       Impact factor: 3.641

View more
  15 in total

1.  Fused tetrazoles as azide surrogates in click reaction: efficient synthesis of N-heterocycle-substituted 1,2,3-triazoles.

Authors:  Buddhadeb Chattopadhyay; Claudia I Rivera Vera; Stepan Chuprakov; Vladimir Gevorgyan
Journal:  Org Lett       Date:  2010-05-07       Impact factor: 6.005

2.  Synthesis of deuterated 1,2,3-triazoles.

Authors:  Hari K Akula; Mahesh K Lakshman
Journal:  J Org Chem       Date:  2012-09-27       Impact factor: 4.354

3.  Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products.

Authors:  Hari K Akula; Hariprasad Kokatla; Graciela Andrei; Robert Snoeck; Dominique Schols; Jan Balzarini; Lijia Yang; Mahesh K Lakshman
Journal:  Org Biomol Chem       Date:  2017-02-01       Impact factor: 3.876

4.  Synthesis and biological properties of C-2 triazolylinosine derivatives.

Authors:  Mahesh K Lakshman; Amit Kumar; Raghavan Balachandran; Billy W Day; Graciela Andrei; Robert Snoeck; Jan Balzarini
Journal:  J Org Chem       Date:  2012-07-03       Impact factor: 4.354

5.  Ruthenium-Catalyzed C-H Bond Activation Approach to Azolyl Aminals and Hemiaminal Ethers, Mechanistic Evaluations, and Isomer Interconversion.

Authors:  Manish K Singh; Hari K Akula; Sakilam Satishkumar; Lothar Stahl; Mahesh K Lakshman
Journal:  ACS Catal       Date:  2016-02-18       Impact factor: 13.084

6.  Structure-activity relationship studies of QS11, a small molecule Wnt synergistic agonist.

Authors:  Manish K Singh; Huanyao Gao; Wei Sun; Zhiquan Song; Robert Schmalzigaug; Richard T Premont; Qisheng Zhang
Journal:  Bioorg Med Chem Lett       Date:  2015-06-23       Impact factor: 2.823

7.  Diarylmethanes through an Unprecedented Palladium-Catalyzed C-C Cross-Coupling of 1-(Aryl)methoxy-1 H-Benzotriazoles with Arylboronic Acids.

Authors:  Manish K Singh; Mahesh K Lakshman
Journal:  ChemCatChem       Date:  2015-11-04       Impact factor: 5.686

8.  A novel bis(pinacolato)diboron-mediated N-O bond deoxygenative route to C6 benzotriazolyl purine nucleoside derivatives.

Authors:  Vikram Basava; Lijia Yang; Padmanava Pradhan; Mahesh K Lakshman
Journal:  Org Biomol Chem       Date:  2016-07-05       Impact factor: 3.876

9.  Triazole-containing monophosphate mRNA cap analogs as effective translation inhibitors.

Authors:  Karolina Piecyk; Maciej Lukaszewicz; Edward Darzynkiewicz; Marzena Jankowska-Anyszka
Journal:  RNA       Date:  2014-08-22       Impact factor: 4.942

10.  The "Speedy" Synthesis of Atom-Specific (15)N Imino/Amido-Labeled RNA.

Authors:  Sandro Neuner; Tobias Santner; Christoph Kreutz; Ronald Micura
Journal:  Chemistry       Date:  2015-06-17       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.